DIABETIC FOOT ULCER

A unique investigation is underway in Sancti Spiritus, central Cuba, to provide new evidence on the efficacy of this drug»

The registration of the pharmaceutical was announced in Havana in the first meeting of the Mexico-Cuba Health Cooperation Group»

According to BioCubaFarma enterprise, it is hoped that the Cuban developed medication will soon be available for patients in the United States»

Heberprot-p was created by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB)»

Unique in the world to treat advanced foot ulcers in diabetic patients, the Cuban drug Heberprot-P has already been registered in 23 countries, it was informed today»

Cuba reduced by over 78 percent the relative risk of amputation due to diabetic foot ulcers, thanks to a comprehensive program of care for these patients that includes the use of the drug Heberprot-P.»

Heberprot-P is a unique drug developed in Cuba.»

The Cuban product Heberprot-p, to cure complaints resulting from diabetes, is welcomed in Ecuador for the results reported by patients with treatment in this South American country.»

Some 70 patients in Sancti Spiritus province suffering from different carcinogenic pathologies are included in the various clinical trials developed in the Cuban central territory, as part of the treatment against cancer, disease which consitutes the first cause of death in the region.»

The Cuba-made medication Heberprot-P, used in the treatment of diabetic foot ulcers, has entered the second phase of clinical trials in Europe.»